![3-[[4-[2-[1-[(2S,3R,4R,5R)-6-carboxy-3,4,5-trihydroxy-tetrahydropyran-2-yl]tetrazol-5-yl]phenyl]ph…](https://static.cymitquimica.com/cas-image/312639-3-4-2-1-2s-3r-4r-5r-6-carboxy-345-trihydroxy-tetrahydropyran-2-yl-tetrazol-5-yl-phenyl-phenyl-methyl-2-ethoxy-benzimidazole-4-carboxylic-acid.png)
CAS: 180603-76-3 - 3-[[4-[2-[1-[(2S,3R,4R,5R)-6-carboxy-3,4,5-trihydroxy-tetrahydropyran-2-yl]tetrazol-5-yl]phenyl]phenyl]methyl]-2-ethoxy-benzimidazole-4-carboxylic acid
Formula:C30H28N6O9
InChI:InChI=1/C30H28N6O9/c1-2-44-30-31-20-9-5-8-19(28(40)41)21(20)35(30)14-15-10-12-16(13-11-15)17-6-3-4-7-18(17)26-32-33-34-36(26)27-24(39)22(37)23(38)25(45-27)29(42)43/h3-13,22-25,27,37-39H,2,14H2,1H3,(H,40,41)(H,42,43)/t22-,23-,24-,25?,27+/m1/s1
![β-D-Glucopyranuronic acid, 1-[5-[4'-[(7-carboxy-2-ethoxy-1H-benzimidazol-1-yl)methyl][1,1'-bipheny…](https://static.cymitquimica.com/products/IN/thumb/DA00225Q.jpg)
β-D-Glucopyranuronic acid, 1-[5-[4'-[(7-carboxy-2-ethoxy-1H-benzimidazol-1-yl)methyl][1,1'-biphenyl]-2-yl]-2H-tetrazol-2-yl]-1-deoxy-
CAS:180603-76-3
Formula:
C30H28N6O9
Color and Shape:
Solid
Molecular weight:
616.5781
Ref: IN-DA00225Q
| Undefined size | To inquire |
Estimated delivery in United States, on Monday 18 Nov 2024
Candesartan N2-Glucuronide Ditriethylamine Salt
CAS:180603-76-3
Formula:
C30H28N6O9Et3N
Molecular weight:
616.59 2*101.19
Ref: 4Z-C-0152
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 19 Nov 2024
Candesartan N2-glucuronide
CAS:180603-76-3
Candesartan N-glucuronide is a metabolite of candesartan. It is produced by human UDP-glucuronosyltransferase, which belongs …
Formula:
C30H28N6O9
Purity:
Min. 95%
Molecular weight:
616.58 g/mol
Ref: 3D-MC09817
| 2mg | 1,855.00 € | ||
| 5mg | 3,130.00 € | ||
| 10mg | 5,008.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
